Celestica: You Haven't Seen Anything Yet

Celestica is forecast to nearly double FY2027 revenue to $40 billion, with EPS projected at $21.50 per share. Q3 2026 adjusted operating margin reached 8.5%, while the article cites a valuation of 13.4x FY2027 EPS versus 21.7x FY2026 forward P/E, framing the shares as compelling value amid AI-related growth.

Analysis

The key risk is not whether AI infrastructure demand exists, but whether Celestica converts a small set of large programs into sustained, cash-generative revenue. Customer concentration and hyperscaler bargaining power can turn strong order growth into weaker-than-expected pricing and margins; competing contract manufacturers such as Flex and Jabil could also bid aggressively for the same programs. Rapid scaling raises execution, component-availability, and working-capital risks, so EPS estimates deserve less confidence until cash conversion and backlog conversion corroborate them.

The valuation case is unusually sensitive to the out-year denominator: a modest delay or reduction in FY27 expectations would both lower estimated earnings and compress the multiple investors are willing to pay for distant growth. Near term, watch quarterly revenue, adjusted operating margin, inventory/receivables, and management commentary on customer programs—not headline AI demand alone. Over 6–18 months, the structural upside depends on AI spending broadening across customers and Celestica retaining economics as capacity expands. A pause in hyperscaler capex, program insourcing, or evidence of margin dilution would reverse the thesis. The bullish framing may underweight the possibility that investors already price substantial execution success; without current price, peer valuation, backlog, and customer-concentration data, the apparent out-year discount is not enough to establish undervaluation.

Key Decisions for Investors

• Do not chase solely on the out-year EPS multiple. Before adding, verify the latest share price and valuation against current-year estimates, order/backlog conversion, and cash-flow trends; treat management targets as conditional, not realized earnings.
• For a 1–3 month catalyst watch, track quarterly revenue and margin delivery alongside receivables, inventory, and operating cash flow. Strong sales with deteriorating cash conversion or margin would weaken the quality of the growth and is a reason to reduce exposure.
• For a 6–18 month expression, consider a staged long CLS only if program growth is confirmed across more than one customer and margins hold as volumes scale. Falsify the thesis on material guidance reductions, repeated margin misses, or evidence of customer insourcing; set position risk around those events rather than an unsupported price target.
• A relative-value long CLS versus a diversified electronics-manufacturing peer basket is a watch idea, not yet a recommendation: first compare valuation, customer concentration, backlog quality, and cash conversion. Avoid the pair if CLS's premium is already large or its program economics are not demonstrably superior.